Live Research Database
Psoriasis
Hub: New York, NY
Connecting patients in New York with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in New York
Available Psoriasis Opportunities
9 RecruitingNCT06857942(Verify)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RECRUITING
Psoriasis
NCT03816345(Verify)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RECRUITING
Psoriasis
NCT07116967(Verify)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
RECRUITING
Psoriasis
NCT07426120(Verify)
Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)
RECRUITING
Psoriasis
NCT02418442(Verify)
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RECRUITING
Psoriasis
NCT07449702(Verify)
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
RECRUITING
Psoriasis
NCT07474792(Verify)
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
RECRUITING
Psoriasis
NCT05669833(Verify)
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in New York through safe, transparent, and patient-first clinical trials."
Research Hubs in New York
Explore other local breakthroughs
Psoriasis Hubs in NY
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT